Along with potential vision problems, stomach issues and speech difficulties, one common effect of the neurological condition multiple sclerosis (MS) is having trouble walking. Researchers behind a new year long study explored the results of a medication aimed at improving walking in people who have MS.

The FDA gave new warnings for Ampyra . Some people taking this drug for Multiple Sclerosis may be at risk of having seizures in the first few days or weeks of taking the drug.